Most Recent Articles by Natasha Persaud
In a randomized study of patients with heart failure, including some with concurrent chronic kidney disease, patients who received vitamin D supplements or placebo had similar changes in hemoglobin levels over 36 months.
Each 1-mg/dL increase in serum phosphorus among kidney transplant recipients is associated with 36% and 21% increased risk in graft failure and death, respectively.
Phase 2 randomized placebo-controlled trial demonstrated the safety and efficacy of sevelamer in lowering serum phosphorus levels in children and adolescents.
Surgical complications and symptom improvement, for example, did not differ significantly between total parathyroidectomy with and without autotransplantation.
The risk for premature death increased by 62% and 42% for stage 3 CKD patients with vitamin D deficiency and elevated parathyroid hormone levels, respectively.
More Articles by Natasha Persaud
Renal and Urology News Articles
- Immunotherapy Superior to Sunitinib for Front-Line mRCC Treatment
- Anagliptin Improves LDL Partly Via ApoB-100 Suppression
- First Metastasis Site Predicts Prostate Cancer-Specific Survival
- High Phosphorus Ups Risk of Kidney Transplant Failure, Death
- Total Parathyroidectomy Procedures Similarly Efficacious
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)